Valneva
high dose vaccination protects against challenge induced aes high dose after single vaccination | Valneva
Company
Deck Type
IPO
Sector
Industry
Deck date
April 2021
Slide
21 of 41
Related slides by other companies
Grab
Results
September 2021
partnering governments on vaccinations covid update | Grab
ATAI
Investor Presentation
October 2022
phase a efficacy data symbol coding category fluency data confirmed activity in schizophrenia population improved dose dependent widespread changes observed across brain regions symbol coding day day increased alpha middle high doses decreased beta dose observed elevations in resting state alpha increased and decreased suggesting a relaxed wakeful state without drowsiness at the mid to high dose levels has previously shown pro cognitive effects human clinical studies study showed wide spread beneficial | ATAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io